CASP1 and viral infectious disease: Remarkably, the NLRP3 inflammasome inhibitor MCC950 significantly reduced caspase-1 activity, aligning with previous studies that have demonstrated a central role for NLRP3 in inflammasome activation during viral infections [46,47].